{"component": "definition", "props": {"groups": [{"snippet": "means, with respect to each $1,000 principal amount of Securities, the greater of (i) zero and (ii) the product of:", "samples": [{"hash": "lGwZCasl4LI", "uri": "/contracts/lGwZCasl4LI#equity-bonus", "label": "Calculation Agency Agreement (Lehman Brothers Holdings Inc)", "score": 18.0, "published": true}, {"hash": "fyN1MJjYQ6N", "uri": "/contracts/fyN1MJjYQ6N#equity-bonus", "label": "Calculation Agency Agreement (Lehman Brothers Holdings Inc)", "score": 18.0, "published": true}, {"hash": "6d1I8ujKcJe", "uri": "/contracts/6d1I8ujKcJe#equity-bonus", "label": "Calculation Agency Agreement (Lehman Brothers Holdings Inc)", "score": 18.0, "published": true}], "size": 10, "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "amount-of-securities", "type": "clause", "offset": [45, 65]}, {"key": "the-product", "type": "clause", "offset": [100, 111]}], "hash": "6c94f518aecedae4622a942549b29688", "id": 1}, {"snippet": "means a number of shares of Common Stock with an aggregate Market Value equal to 75% of the Principal Amount. \u201cMarket Value\u201d means $0.10 per share of Common Stock. The Purchaser shall have no obligation to provide any additional consideration to the Company for the issuance of the Equity Bonus. The Company shall authorize and reserve sufficient shares of the Company\u2019s capital stock to be issued upon the issuance of the Equity Bonus. The shares of Common Stock comprising the Equity Bonus shall be included in any registration of shares of Common Stock under the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d), occurring after the date hereof.", "samples": [{"hash": "ePenYqZY2cJ", "uri": "/contracts/ePenYqZY2cJ#equity-bonus", "label": "Note Purchase Agreement (BioDrain Medical, Inc.)", "score": 23.8528405202, "published": true}, {"hash": "eEfsi1gE038", "uri": "/contracts/eEfsi1gE038#equity-bonus", "label": "Note Purchase Agreement (BioDrain Medical, Inc.)", "score": 23.8528405202, "published": true}, {"hash": "5C6H51G3XvU", "uri": "/contracts/5C6H51G3XvU#equity-bonus", "label": "Note Purchase Agreement (BioDrain Medical, Inc.)", "score": 23.8528405202, "published": true}], "size": 3, "snippet_links": [{"key": "number-of-shares-of-common-stock", "type": "clause", "offset": [8, 40]}, {"key": "aggregate-market-value", "type": "clause", "offset": [49, 71]}, {"key": "equal-to", "type": "definition", "offset": [72, 80]}, {"key": "the-principal-amount", "type": "definition", "offset": [88, 108]}, {"key": "the-purchaser-shall", "type": "clause", "offset": [164, 183]}, {"key": "no-obligation-to-provide", "type": "clause", "offset": [189, 213]}, {"key": "consideration-to-the-company", "type": "clause", "offset": [229, 257]}, {"key": "issuance-of-the", "type": "clause", "offset": [266, 281]}, {"key": "the-company-shall", "type": "clause", "offset": [296, 313]}, {"key": "shares-of-the-company", "type": "definition", "offset": [347, 368]}, {"key": "stock-to-be-issued", "type": "clause", "offset": [379, 397]}, {"key": "the-shares", "type": "clause", "offset": [437, 447]}, {"key": "registration-of-shares-of-common-stock", "type": "clause", "offset": [517, 555]}, {"key": "securities-act-of-1933", "type": "clause", "offset": [566, 588]}, {"key": "as-amended", "type": "definition", "offset": [590, 600]}, {"key": "date-hereof", "type": "clause", "offset": [645, 656]}], "hash": "83d1b930c6afb7c70a342e57c8452d32", "id": 2}, {"snippet": "means a bonus accrued for and paid in accordance with Section 7.", "samples": [{"hash": "fhr0dlrFATD", "uri": "https://www.sec.gov/Archives/edgar/data/913357/000100547798000848/1.txt", "label": "Financial Security (Financial Security Assurance Holdings LTD/Ny/)", "score": 9.0, "published": false}, {"hash": "broI98jLCh8", "uri": "https://www.sec.gov/Archives/edgar/data/913357/000100547701500522/ex10-1.txt", "label": "Performance Shares Award (Financial Security Assurance Holdings LTD/Ny/)", "score": 6.0, "published": false}, {"hash": "lzBrEJb9wDP", "uri": "https://www.sec.gov/Archives/edgar/data/913357/000100547701003200/0002.txt", "label": "Performance Shares Award (Financial Security Assurance Holdings LTD/Ny/)", "score": 6.0, "published": false}], "size": 3, "snippet_links": [{"key": "in-accordance-with-section-7", "type": "clause", "offset": [35, 63]}], "hash": "4a049771265cada03a81f34726e0543c", "id": 3}, {"snippet": "means a number of shares of Common Stock with an aggregate Market Value of not less than $300,000. \u201cMarket Value\u201d means an amount equal to the Conversion Price (as defined in the Note), as such amount may be adjusted from time to time pursuant to Section 9 of the Note. The Purchaser shall have no obligation to provide any additional consideration to the Company for the issuance of the Equity Bonuses. The Company shall authorize and reserve sufficient shares of the Company\u2019s capital stock to be issued upon the issuance of the Equity Bonuses. Upon the Purchaser\u2019s written request, not later than thirty (30) days after receipt of such request, the Company shall file with the Securities and Exchange Commission (the \u201cSEC\u201d) a registration statement (the \u201cS-1\u201d) with respect to a number of shares of Common Stock not less than such number of shares required to be included in the Equity Bonuses, assuming that advances of funds under the Note in the aggregate of $600,000 have been made. Not later than sixty (60) days following the filing of the S-1 with the SEC, the Company shall cause to be declared effective the registration under the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d), the shares of Common Stock comprising the Equity Bonuses (assuming aggregate advances of funds under the Note of $600,000).", "samples": [{"hash": "hXIKr18Zuyw", "uri": "/contracts/hXIKr18Zuyw#equity-bonus", "label": "Note Purchase Agreement (BioDrain Medical, Inc.)", "score": 23.2532511978, "published": true}], "size": 1, "snippet_links": [{"key": "number-of-shares-of-common-stock", "type": "clause", "offset": [8, 40]}, {"key": "aggregate-market-value", "type": "clause", "offset": [49, 71]}, {"key": "equal-to", "type": "definition", "offset": [130, 138]}, {"key": "conversion-price", "type": "clause", "offset": [143, 159]}, {"key": "the-note", "type": "clause", "offset": [175, 183]}, {"key": "from-time-to-time", "type": "clause", "offset": [217, 234]}, {"key": "pursuant-to-section-9", "type": "clause", "offset": [235, 256]}, {"key": "the-purchaser-shall", "type": "clause", "offset": [270, 289]}, {"key": "no-obligation-to-provide", "type": "clause", "offset": [295, 319]}, {"key": "consideration-to-the-company", "type": "clause", "offset": [335, 363]}, {"key": "issuance-of-the", "type": "clause", "offset": [372, 387]}, {"key": "the-company-shall", "type": "clause", "offset": [404, 421]}, {"key": "shares-of-the-company", "type": "definition", "offset": [455, 476]}, {"key": "stock-to-be-issued", "type": "clause", "offset": [487, 505]}, {"key": "written-request", "type": "definition", "offset": [568, 583]}, {"key": "after-receipt-of", "type": "clause", "offset": [617, 633]}, {"key": "the-securities-and-exchange-commission", "type": "clause", "offset": [676, 714]}, {"key": "a-registration-statement", "type": "definition", "offset": [727, 751]}, {"key": "with-respect-to", "type": "clause", "offset": [764, 779]}, {"key": "in-the-aggregate", "type": "definition", "offset": [945, 961]}, {"key": "following-the", "type": "definition", "offset": [1021, 1034]}, {"key": "registration-under-the-securities-act-of-1933", "type": "clause", "offset": [1120, 1165]}, {"key": "as-amended", "type": "definition", "offset": [1167, 1177]}, {"key": "the-shares", "type": "clause", "offset": [1202, 1212]}, {"key": "aggregate-advances", "type": "definition", "offset": [1269, 1287]}], "hash": "f92ba8b326638331a667cb4e55fdb397", "id": 4}, {"snippet": "means a number of shares of Common Stock with an aggregate Market Value of not less than $225,000 calculated at $0.15 per share or less. \u201cMarket Value\u201d means either (i) the average of the three (3) lowest closing prices of the Common Stock published by Bloomberg L.P. for the forty-five (45) trading days preceding the Closing (the \u201cAverage Trading Price\u201d) or (ii) $0.15 (fifteen cents), whichever is lower. The Purchaser shall have no obligation to provide any additional consideration to the Company for the issuance of the Equity Bonus. The Company shall authorize and reserve sufficient shares of the Company\u2019s capital stock to be issued upon the issuance of the Equity Bonus and any Board Meeting Fees. As of the date hereof, the Market Value was $0.15 or less equaling $0. ____ per share1 and the number of shares of Common Stock required to be included in the Equity Bonus is not less 1,500,000 shares of Common Stock (not including any Board Meeting Fees). Shares issuable as Board Meeting Fees may be issued, if necessary and with both parties\u2019 agreement, under a registration statement in Form S-8 under the Securities Act and the regulations promulgated thereunder.", "samples": [{"hash": "iqoEcryWpWX", "uri": "/contracts/iqoEcryWpWX#equity-bonus", "label": "Note Purchase Agreement (BioDrain Medical, Inc.)", "score": 23.0616016427, "published": true}], "size": 1, "snippet_links": [{"key": "number-of-shares-of-common-stock", "type": "clause", "offset": [8, 40]}, {"key": "aggregate-market-value", "type": "clause", "offset": [49, 71]}, {"key": "closing-prices", "type": "definition", "offset": [205, 219]}, {"key": "the-common-stock", "type": "clause", "offset": [223, 239]}, {"key": "trading-days", "type": "clause", "offset": [292, 304]}, {"key": "the-closing", "type": "definition", "offset": [315, 326]}, {"key": "average-trading-price", "type": "definition", "offset": [333, 354]}, {"key": "the-purchaser-shall", "type": "clause", "offset": [408, 427]}, {"key": "no-obligation-to-provide", "type": "clause", "offset": [433, 457]}, {"key": "consideration-to-the-company", "type": "clause", "offset": [473, 501]}, {"key": "issuance-of-the", "type": "clause", "offset": [510, 525]}, {"key": "the-company-shall", "type": "clause", "offset": [540, 557]}, {"key": "shares-of-the-company", "type": "definition", "offset": [591, 612]}, {"key": "stock-to-be-issued", "type": "clause", "offset": [623, 641]}, {"key": "board-meeting-fees", "type": "clause", "offset": [688, 706]}, {"key": "date-hereof", "type": "clause", "offset": [718, 729]}, {"key": "the-market", "type": "definition", "offset": [731, 741]}, {"key": "shares-issuable", "type": "clause", "offset": [965, 980]}, {"key": "both-parties", "type": "definition", "offset": [1040, 1052]}, {"key": "a-registration-statement", "type": "definition", "offset": [1071, 1095]}, {"key": "form-s-8", "type": "definition", "offset": [1099, 1107]}, {"key": "the-securities-act", "type": "clause", "offset": [1114, 1132]}, {"key": "the-regulations", "type": "clause", "offset": [1137, 1152]}], "hash": "2a3d127f0a2bbbdfca8e37b238c6cbdb", "id": 5}, {"snippet": "means a bonus determined in the manner, and payable to certain employees of the Company, described under Item 1 on Schedule 5.01 of the Company Disclosure Letter in an amount equal to Fifteen Million Dollars ($15,000,000). The Equity Bonus shall be payable to such employees as follows: (a) one-third (1/3rd) of the aggregate portion of the Equity Bonus allocated to any employee shall be due and payable on the eightieth (80th) day following the Effective Time of the Merger and (b) the remaining portion of the Equity Bonus allocated to such employee will be payable on the fifteen (15) month anniversary of the Effective Time. To the extent that any employee who is entitled to an Equity Bonus payment is terminated following the Effective Time without cause or terminates his or her employment for good reason (as the terms cause and good reason are defined in the SPARTA, Inc. Employee Severance Plan), then any unpaid Equity Bonus payments allocated to such employee shall be paid to such former employee at the same time as they are paid to continuing employees of the Surviving Corporation.", "samples": [{"hash": "kZ3pwBUmtZ7", "uri": "/contracts/kZ3pwBUmtZ7#equity-bonus", "label": "Merger Agreement (Sparta Inc /De)", "score": 21.0, "published": true}], "size": 1, "snippet_links": [{"key": "payable-to", "type": "definition", "offset": [44, 54]}, {"key": "employees-of-the-company", "type": "clause", "offset": [63, 87]}, {"key": "item-1", "type": "clause", "offset": [105, 111]}, {"key": "on-schedule", "type": "definition", "offset": [112, 123]}, {"key": "company-disclosure-letter", "type": "definition", "offset": [136, 161]}, {"key": "equal-to", "type": "definition", "offset": [175, 183]}, {"key": "allocated-to", "type": "definition", "offset": [354, 366]}, {"key": "any-employee", "type": "clause", "offset": [367, 379]}, {"key": "due-and-payable", "type": "definition", "offset": [389, 404]}, {"key": "the-effective-time-of-the-merger", "type": "clause", "offset": [443, 475]}, {"key": "remaining-portion", "type": "definition", "offset": [488, 505]}, {"key": "employee-will", "type": "clause", "offset": [544, 557]}, {"key": "to-the-extent", "type": "clause", "offset": [630, 643]}, {"key": "without-cause", "type": "definition", "offset": [748, 761]}, {"key": "for-good-reason", "type": "clause", "offset": [798, 813]}, {"key": "the-terms", "type": "definition", "offset": [818, 827]}, {"key": "cause-and-good-reason", "type": "clause", "offset": [828, 849]}, {"key": "severance-plan", "type": "clause", "offset": [891, 905]}, {"key": "bonus-payments", "type": "definition", "offset": [931, 945]}, {"key": "former-employee", "type": "clause", "offset": [995, 1010]}, {"key": "continuing-employees", "type": "definition", "offset": [1048, 1068]}, {"key": "the-surviving-corporation", "type": "clause", "offset": [1072, 1097]}], "hash": "482f2a4b1a1e1236ee525c8081a79e77", "id": 6}, {"snippet": "means and include the terms", "samples": [{"hash": "1LE4cfFyTG9", "uri": "/contracts/1LE4cfFyTG9#equity-bonus", "label": "Employment Agreement (Playboy Enterprises Inc)", "score": 18.0, "published": true}], "size": 1, "snippet_links": [{"key": "the-terms", "type": "definition", "offset": [18, 27]}], "hash": "9640953fd9baf4453d24cf575c5e108d", "id": 7}, {"snippet": "means a number of shares of Common Stock with an aggregate Market Value of not less than $225,000. \u201cMarket Value\u201d means either (i) the average of the three (3) lowest closing prices of the Common Stock published by Bloomberg L.P. for the forty-five (45) trading days preceding the Closing (the \u201cAverage Trading Price\u201d) or (ii) $0.15 (fifteen cents), whichever is lower. The Purchaser shall have no obligation to provide any additional consideration to the Company for the issuance of the Equity Bonus. The Company shall authorize and reserve sufficient shares of the Company\u2019s capital stock to be issued upon the issuance of the Equity Bonus and any Board Meeting Fees. As of the date hereof, the Market Value was $0.15 per share and the number of shares of Common Stock required to be included in the Equity Bonus is not less than 1,500,000 shares of Common Stock (not including any Board Meeting Fees).", "samples": [{"hash": "gLYkdfYWadJ", "uri": "/contracts/gLYkdfYWadJ#equity-bonus", "label": "Note Purchase Agreement (BioDrain Medical, Inc.)", "score": 23.2532511978, "published": true}], "size": 1, "snippet_links": [{"key": "number-of-shares-of-common-stock", "type": "clause", "offset": [8, 40]}, {"key": "aggregate-market-value", "type": "clause", "offset": [49, 71]}, {"key": "closing-prices", "type": "definition", "offset": [167, 181]}, {"key": "the-common-stock", "type": "clause", "offset": [185, 201]}, {"key": "trading-days", "type": "clause", "offset": [254, 266]}, {"key": "the-closing", "type": "definition", "offset": [277, 288]}, {"key": "average-trading-price", "type": "definition", "offset": [295, 316]}, {"key": "the-purchaser-shall", "type": "clause", "offset": [370, 389]}, {"key": "no-obligation-to-provide", "type": "clause", "offset": [395, 419]}, {"key": "consideration-to-the-company", "type": "clause", "offset": [435, 463]}, {"key": "issuance-of-the", "type": "clause", "offset": [472, 487]}, {"key": "the-company-shall", "type": "clause", "offset": [502, 519]}, {"key": "shares-of-the-company", "type": "definition", "offset": [553, 574]}, {"key": "stock-to-be-issued", "type": "clause", "offset": [585, 603]}, {"key": "board-meeting-fees", "type": "clause", "offset": [650, 668]}, {"key": "date-hereof", "type": "clause", "offset": [680, 691]}, {"key": "the-market", "type": "definition", "offset": [693, 703]}], "hash": "e64349cfe6a53258bd4813748e0e4be0", "id": 8}, {"snippet": "means any stock, option, warrant, or similar right that is granted to or exercised by the \u2587\u2587\u2587\u2587\u2587 Partner, in each case in connection with services rendered by the \u2587\u2587\u2587\u2587\u2587 Partner, and (iii) \u201cSalary\u201d means the regular monthly payments described above plus any severance paid to the \u2587\u2587\u2587\u2587\u2587 Partner during the term hereof, but excluding any Cash Bonus, Equity Bonus, benefits (including medical benefits subsidy paid to Employee), and other compensation. All compensation payable or deliverable to \u2587\u2587\u2587\u2587\u2587 is referred to herein as the \u201cResource Fee.\u201d In lieu of the \u2587\u2587\u2587\u2587\u2587 Partner participating in the Company-sponsored employee medical/dental insurance benefit, the \u2587\u2587\u2587\u2587\u2587 Partner will remain on his or her current medical/dental plan. The Company will reimburse the \u2587\u2587\u2587\u2587\u2587 Partner for amounts paid by the \u2587\u2587\u2587\u2587\u2587 Partner for such medical/dental insurance for himself and (where applicable) his family of up to $ 324.00 per month upon presentation of reasonable documentation of premiums paid by the \u2587\u2587\u2587\u2587\u2587 Partner. In accordance with the U.S. federal tax law, such amount will not be considered reportable W-2 income, but instead non-taxable benefits expense. As an employee, the \u2587\u2587\u2587\u2587\u2587 Partner will be eligible for any Company employee retirement and/or 401(k) plan and for vacation and holidays consistent with the Company\u2019s policy as it applies to senior management, and the \u2587\u2587\u2587\u2587\u2587 Partner will be exempt from any delay periods otherwise required for eligibility. Payments to \u2587\u2587\u2587\u2587\u2587 should be made by direct deposit through the Company\u2019s payroll, or by an automated clearing house (\u201cACH\u201d) payment at the same time as payments are made to the Employee. If such payment method is not available and payments are made by check, \u2587\u2587\u2587\u2587\u2587 will issue invoices to the Company, and the Company agrees to pay such invoices no later than ten (10) days after receipt of invoices. The Company will reimburse the \u2587\u2587\u2587\u2587\u2587 Partner directly for out-of-pocket expenses incurred by the \u2587\u2587\u2587\u2587\u2587 Partner in providing services hereunder to the same extent that the Company is responsible for such expenses of senior managers of the Company. The Company will have the opportunity to make the \u2587\u2587\u2587\u2587\u2587 Partner a permanent member of Company management at any time during the term of this agreement by entering into another form of \u2587\u2587\u2587\u2587\u2587 agreement, the terms of which will be negotiated at such time. During the twelve (12)-month period following termination or expiration of this agreement, other than in connection with conversion to a Permanent Employee under the previous paragraph, the Company will not employ the \u2587\u2587\u2587\u2587\u2587 Partner, or engage the \u2587\u2587\u2587\u2587\u2587 Partner as an independent contractor, to render services of substantially the same nature as those to be performed by the \u2587\u2587\u2587\u2587\u2587 Partner as contemplated by this agreement. The parties recognize and agree that a breach by the Company of this provision would result in the loss to \u2587\u2587\u2587\u2587\u2587 of the \u2587\u2587\u2587\u2587\u2587 Partner\u2019s valuable expertise and revenue potential and that such injury will be impossible or very difficult to ascertain. Therefore, in the event this provision is breached, \u2587\u2587\u2587\u2587\u2587 will be entitled to receive as liquidated damages an amount equal to twenty-five percent (25%) of the \u2587\u2587\u2587\u2587\u2587 Partner\u2019s Annualized Compensation (as defined below), which amount the parties agree is reasonably proportionate to the probable loss to \u2587\u2587\u2587\u2587\u2587 and is not intended as a penalty. The amount will be due and payable to \u2587\u2587\u2587\u2587\u2587 upon written demand to the Company. For this purpose, ''Annualized Compensation\u2019\u2019 will mean monthly Salary equivalent to what the \u2587\u2587\u2587\u2587\u2587 Partner would receive on a full-time basis multiplied by twelve (12), plus the maximum amount of any Cash Bonus for which the \u2587\u2587\u2587\u2587\u2587 Partner was eligible with respect to the then current bonus year, and which the \u2587\u2587\u2587\u2587\u2587 Partner had a reasonable opportunity to receive given any relevant performance or other criteria and/or the Company\u2019s then-current bonus practices, provided that such payment shall be pro rated on the basis of the number of days the \u2587\u2587\u2587\u2587\u2587 Partner actually performed services hereunder within the applicable annual bonus period.", "samples": [{"hash": "eiiRWuAlSG5", "uri": "/contracts/eiiRWuAlSG5#equity-bonus", "label": "Executive Services Agreement (LCC International Inc)", "score": 16.0, "published": true}], "size": 1, "snippet_links": [{"key": "granted-to", "type": "clause", "offset": [59, 69]}, {"key": "the-\u2587", "type": "clause", "offset": [86, 91]}, {"key": "each-case", "type": "definition", "offset": [108, 117]}, {"key": "in-connection-with", "type": "clause", "offset": [118, 136]}, {"key": "services-rendered", "type": "definition", "offset": [137, 154]}, {"key": "monthly-payments", "type": "clause", "offset": [214, 230]}, {"key": "but-excluding", "type": "clause", "offset": [316, 329]}, {"key": "cash-bonus", "type": "definition", "offset": [334, 344]}, {"key": "medical-benefits", "type": "definition", "offset": [380, 396]}, {"key": "to-employee", "type": "definition", "offset": [410, 421]}, {"key": "other-compensation", "type": "clause", "offset": [428, 446]}, {"key": "compensation-payable", "type": "clause", "offset": [452, 472]}, {"key": "in-lieu-of", "type": "clause", "offset": [542, 552]}, {"key": "participating-in", "type": "definition", "offset": [571, 587]}, {"key": "employee-medical", "type": "clause", "offset": [610, 626]}, {"key": "dental-insurance-benefit", "type": "clause", "offset": [627, 651]}, {"key": "dental-plan", "type": "clause", "offset": [713, 724]}, {"key": "the-company-will", "type": "clause", "offset": [726, 742]}, {"key": "insurance-for", "type": "clause", "offset": [833, 846]}, {"key": "where-applicable", "type": "clause", "offset": [860, 876]}, {"key": "per-month", "type": "clause", "offset": [907, 916]}, {"key": "reasonable-documentation", "type": "clause", "offset": [938, 962]}, {"key": "in-accordance-with", "type": "definition", "offset": [1002, 1020]}, {"key": "the-us", "type": "clause", "offset": [1021, 1028]}, {"key": "federal-tax-law", "type": "definition", "offset": [1030, 1045]}, {"key": "taxable-benefits", "type": "clause", "offset": [1121, 1137]}, {"key": "as-an-employee", "type": "clause", "offset": [1147, 1161]}, {"key": "employee-retirement", "type": "definition", "offset": [1214, 1233]}, {"key": "vacation-and-holidays", "type": "clause", "offset": [1261, 1282]}, {"key": "consistent-with-the", "type": "clause", "offset": [1283, 1302]}, {"key": "applies-to", "type": "clause", "offset": [1326, 1336]}, {"key": "senior-management", "type": "definition", "offset": [1337, 1354]}, {"key": "delay-periods", "type": "clause", "offset": [1402, 1415]}, {"key": "payments-to", "type": "definition", "offset": [1452, 1463]}, {"key": "direct-deposit", "type": "clause", "offset": [1488, 1502]}, {"key": "automated-clearing-house", "type": "definition", "offset": [1543, 1567]}, {"key": "to-the-employee", "type": "definition", "offset": [1622, 1637]}, {"key": "payment-method", "type": "definition", "offset": [1647, 1661]}, {"key": "not-available", "type": "definition", "offset": [1665, 1678]}, {"key": "and-payments", "type": "clause", "offset": [1679, 1691]}, {"key": "by-check", "type": "clause", "offset": [1701, 1709]}, {"key": "to-the-company", "type": "clause", "offset": [1737, 1751]}, {"key": "to-pay", "type": "clause", "offset": [1776, 1782]}, {"key": "after-receipt-of", "type": "clause", "offset": [1825, 1841]}, {"key": "expenses-incurred", "type": "clause", "offset": [1924, 1941]}, {"key": "providing-services", "type": "clause", "offset": [1966, 1984]}, {"key": "to-the-same-extent", "type": "definition", "offset": [1995, 2013]}, {"key": "responsible-for", "type": "clause", "offset": [2034, 2049]}, {"key": "expenses-of", "type": "clause", "offset": [2055, 2066]}, {"key": "managers-of-the-company", "type": "clause", "offset": [2074, 2097]}, {"key": "the-opportunity", "type": "clause", "offset": [2121, 2136]}, {"key": "permanent-member", "type": "definition", "offset": [2165, 2181]}, {"key": "company-management", "type": "definition", "offset": [2185, 2203]}, {"key": "at-any-time", "type": "clause", "offset": [2204, 2215]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [2216, 2249]}, {"key": "entering-into", "type": "clause", "offset": [2253, 2266]}, {"key": "form-of", "type": "definition", "offset": [2275, 2282]}, {"key": "terms-of", "type": "clause", "offset": [2304, 2312]}, {"key": "termination-or-expiration-of-this-agreement", "type": "clause", "offset": [2398, 2441]}, {"key": "a-permanent-employee", "type": "clause", "offset": [2487, 2507]}, {"key": "independent-contractor", "type": "definition", "offset": [2619, 2641]}, {"key": "render-services", "type": "definition", "offset": [2646, 2661]}, {"key": "performed-by", "type": "clause", "offset": [2710, 2722]}, {"key": "contemplated-by-this-agreement", "type": "clause", "offset": [2744, 2774]}, {"key": "the-parties-recognize", "type": "clause", "offset": [2776, 2797]}, {"key": "breach-by-the-company", "type": "definition", "offset": [2815, 2836]}, {"key": "loss-to", "type": "clause", "offset": [2875, 2882]}, {"key": "in-the-event", "type": "clause", "offset": [3036, 3048]}, {"key": "to-receive", "type": "definition", "offset": [3100, 3110]}, {"key": "liquidated-damages", "type": "definition", "offset": [3114, 3132]}, {"key": "equal-to", "type": "definition", "offset": [3143, 3151]}, {"key": "five-percent", "type": "clause", "offset": [3159, 3171]}, {"key": "annualized-compensation", "type": "clause", "offset": [3201, 3224]}, {"key": "the-parties-agree", "type": "clause", "offset": [3258, 3275]}, {"key": "payable-to", "type": "definition", "offset": [3395, 3405]}, {"key": "written-demand", "type": "definition", "offset": [3417, 3431]}, {"key": "salary-equivalent", "type": "clause", "offset": [3512, 3529]}, {"key": "time-basis", "type": "clause", "offset": [3580, 3590]}, {"key": "maximum-amount", "type": "definition", "offset": [3627, 3641]}, {"key": "with-respect-to", "type": "clause", "offset": [3701, 3716]}, {"key": "bonus-year", "type": "definition", "offset": [3734, 3744]}, {"key": "relevant-performance", "type": "definition", "offset": [3824, 3844]}, {"key": "other-criteria", "type": "clause", "offset": [3848, 3862]}, {"key": "provided-that", "type": "clause", "offset": [3914, 3927]}, {"key": "basis-of", "type": "clause", "offset": [3967, 3975]}, {"key": "number-of-days", "type": "definition", "offset": [3980, 3994]}, {"key": "annual-bonus-period", "type": "definition", "offset": [4073, 4092]}], "hash": "2b633638893743c6af765e4270daeb4a", "id": 9}, {"snippet": "means for a Plan Year an amount equal to the product of (i) the portion of the Participant\u2019s Annual Bonus Pool Percentage allocable to the Participant\u2019s Equity Bonus Pool Percentage and (ii) the Bonus Pool, provided that, as of the Effective Date, the Deferred Bonus for members of the Company\u2019s senior management shall be twenty-five percent (25%) of the Bonus Pool allocable to such individuals, subject to adjustment by the Committee in Future Plan Years.", "samples": [{"hash": "xGvEN1U6DO", "uri": "https://www.sec.gov/Archives/edgar/data/1410997/000114420412013319/v304844_ex10-7.htm", "label": "Incentive Compensation Plan (American Realty Capital Trust, Inc.)", "score": 9.1765913758, "published": false}], "size": 1, "snippet_links": [{"key": "equal-to", "type": "definition", "offset": [32, 40]}, {"key": "the-product", "type": "clause", "offset": [41, 52]}, {"key": "the-participant", "type": "clause", "offset": [75, 90]}, {"key": "bonus-pool-percentage", "type": "definition", "offset": [100, 121]}, {"key": "the-bonus", "type": "definition", "offset": [191, 200]}, {"key": "provided-that", "type": "clause", "offset": [207, 220]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [222, 246]}, {"key": "deferred-bonus", "type": "definition", "offset": [252, 266]}, {"key": "members-of-the-company", "type": "clause", "offset": [271, 293]}, {"key": "senior-management", "type": "definition", "offset": [296, 313]}, {"key": "five-percent", "type": "clause", "offset": [330, 342]}, {"key": "subject-to", "type": "definition", "offset": [398, 408]}, {"key": "the-committee", "type": "clause", "offset": [423, 436]}, {"key": "plan-years", "type": "clause", "offset": [447, 457]}], "hash": "4facf6bf3eb5be39e3e15096869c45ad", "id": 10}], "next_curs": "ClkSU2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjULEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIVZXF1aXR5LWJvbnVzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means, with respect to each $1,000 principal amount of Securities, the greater of (i) zero and (ii) the product of:", "size": 29, "title": "Equity Bonus", "id": "equity-bonus", "examples": ["Until or unless the Company and the Committee establish performance goals, the Executive\u2019s discretionary Cash Bonus and equity-based compensation (including the <strong>Equity Bonus</strong>) will be wholly discretionary.", "The <strong>Equity Bonus</strong> can only be applied to new direct clients who open live accounts at the Company and have never participated in the promotion of &quot;The 100% First Deposit Bonus&quot;.", "During the Term, the Executive shall be eligible to receive equity and equity-based awards (including the <strong>Equity Bonus</strong>) in the discretion of the Board or the Committee and on such terms and conditions as determined by the Board or the Committee.", "The <strong>Equity Bonus</strong> may be in the form of common stock, stock options or other equity consideration, in such amounts and with such terms as may be determined by the Committee or the Board, with the recommendation of the Committee, from time to time.", "The Executive and the Company agree that the Executive\u2019s discretionary Cash Bonus and equity-based compensation (including the <strong>Equity Bonus</strong>) may, but shall not be required to, be based on the Executive\u2019s and the Company\u2019s achievement of performance goals that may be established by the Committee after discussion with the Executive and his supervisors (if any).", "The Company shall not be in breach of this provision unless it can be demonstrated that the Company acted in bad faith in determining whether to award (or the size of an award of) a Cash Bonus or LT <strong>Equity Bonus</strong>, which determination of bad faith shall specifically be made with reference to the target awards set for other officers and the actual awards paid other officers.", "The <strong>Equity Bonus</strong> shall be in a form and subject to terms and conditions, including claw-back provisions, determined by the Company and consistent with those of equity awards to comparable senior executives of the Company.", "Any equity and equity-based awards (including the <strong>Equity Bonus</strong>) granted to the Executive, whether before or after the Execution Date, shall be governed by the terms and conditions of the applicable Company equity incentive plan(s), as may be in effect from time to time, and the award agreements governing such equity or equity-based awards (any such plan and award agreements, collectively, the \u201cEquity Agreements\u201d).", "Except as specified in ARTICLE IV regarding the payment of a bonus and other compensation following Executive\u2019s termination of employment under certain circumstances, nothing herein shall require the Committee or the Board to pay any bonus, including any Cash Bonus or <strong>Equity Bonus</strong>.", "The Purchaser shall have no obligation to provide any additional consideration to the Company for the issuance of the <strong>Equity Bonus</strong>."], "related": [["cash-bonus", "Cash Bonus", "Cash Bonus"], ["performance-bonus", "Performance Bonus", "Performance Bonus"], ["incentive-bonus", "Incentive Bonus", "Incentive Bonus"], ["density-bonus", "Density bonus", "Density bonus"], ["annual-bonus", "Annual Bonus", "Annual Bonus"]], "related_snippets": [], "updated": "2025-07-06T21:58:36+00:00"}, "json": true, "cursor": ""}}